science.bio retatrutide 30mg Retatrutide: The future of metabolic

GLP-1 receptor agonists like Ozempic , Wegovy , Mounjaro , and Zepbound are transforming how we approach weight loss, blood sugar control, and metabolic health

Aim for: Regular walking or low impact cardio Strength training two or more days per week to preserve muscle Gentle activities such as yoga or Pilates to support stress management and mobility 5

GLP-1 drugs have become one of the most closely watched areas in Koreas drug market since Novo Nordisks Wegovy (semaglutide) launched in October 2024 and Mounjaro entered the market in 2025

How effective is retatrutide for subcutaneous fat loss

Cigna may require step therapy, meaning patients must try a less expensive medication such as Contrave before the insurer approves a GLP-1 agonist

However, their use raises important clinical considerations